Highly active antiretroviral therapy (HAART) has had a major impact on the clinical management of HIV-1 infection. However, the emergence of resistant variants requires that follow-up drug regimens be optimized to maximum therapeutic effect. This article focuses on bioinformatics approaches that can be used to support anti-HIV therapy.
- Thomas Lengauer
- Tobias Sing
